Home
Syndromes
Formulas
Chinese patent drugs
Chinese Medicinal Materials
Ingredients
Targets
Diseases
Q&A
Tools
Data annotation
Data Mining
Enrichment analysis
Network localization and separation
Knowledge graph
Help
Basic Information
Structure
ID
TCMI02961
Ingredient name
(S)-bupropion
Formula
C13H18ClNO
PubChem CID
667684
InChIKey
SNPPWIUOZRMYNY-VIFPVBQESA-N
IUPAC name
(2S)-2-(tert-butylamino)-1-(3-chlorophenyl)propan-1-one
Canonical SMILES
CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C
Isomeric SMILES
C[C@@H](C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C
Physicochemical Property
Property
Value
Property
Value
Property
Value
Molecular Weight (MW)
239.74
Volume
249.3
Density
0.959
nHA
2
nHD
1
nRot
4
nRing
1
MaxRing
6
nHet
3
Eye Irritation
0.011
fChar
0
nRig
7
Flexibility
0.571
Stereo Centers
1
TPSA
29.1
logS
-3.0
logP
logD
3.0
Drug-likeness
Lipinski rule-of-five:(All of the following data projections are from ADMET)
Term
Value
Judgment
The average molecular weight (MolWt)
239.74
No
Number of Hydrogen Bond Acceptors (NumHAcceptors)
2
Yes
Number of Hydrogen Bond Donors (NumHDonors)
1
Yes
Wildman-Crippen LogP value (MolLogP)
3.0
No
Number of Rotatable Bonds (NumRotatableBonds)
4
Yes
Quantitative estimation of drug-likeness
:
0.82
Toxicity
Property
Value
Property
Value
Property
Value
hERG Blockers
0.066
H-HT
0.638
DILI
0.052
AMES
0.008
Rat Oral Acute Toxicity
0.606
FDAMDD
0.876
Skin Sensitization
0.165
Carcinogencity
0.037
Eye Corrosion
0.004
Eye Irritation
0.011
Respiratory Toxicity
0.9
Bioconcentration Factors
1.401
IGC50
3.728
LC50FM
LC50DM
3.707
NR-AR
0.001
NR-AR-LBD
0.001
NR-AhR
0.025
NR-Aromatase
0.004
NR-ER
0.362
NR-ER-LBD
0.072
NR-PPAR-gamma
0.003
SR-ARE
0.037
SR-ATAD5
0.003
SR-HSE
0.01
SR-MMP
0.04
Related Targets
Related Chinese Medicinal Materials
Related Diseases
ID
Disease
P_value
TCMD22207
Squamous cell carcinoma of lung
1.0454478747e-04
TCMD23677
Unipolar Depression
1.1056905941e-04
TCMD13474
Liver carcinoma
1.1073508465e-02
TCMD03583
Carcinoma of lung
1.1104212881e-05
TCMD09562
Glaucoma, Open-Angle
1.1520675746e-02
«
1
2
3
…
31
»
BACK